Bender Jeremy (CIK 1863107) reported 47 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-08). Recent activity: Buy AURA (30,000 shares), Sell DAWN (204,643 shares), Sell DAWN (20,204 shares), Sell DAWN (300,000 shares), Sell DAWN (147,702 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Aura Biosciences, Inc. (AURA) | Director | Buy | 30,000 | $0 |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 204,643 | $0 |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 20,204 | $0 |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 300,000 | $0 |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 147,702 | $0 |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 18,197 | $0 |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 300,000 | $0 |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 808,285 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 4,750 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 11,688 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 11,687 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 14,812 | $0 |
| 2026-02-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 15,459 | $179,324 |
| 2025-11-26 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 300,000 | $0 |
| 2025-11-26 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 300,000 | $0 |
| 2025-11-26 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 300,000 | $0 |
| 2025-11-26 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 300,000 | $0 |
| 2025-11-26 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 7,225 | $0 |
| 2025-11-26 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 7,225 | $0 |
| 2025-11-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 3,570 | $0 |
| 2025-11-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 4,750 | $0 |
| 2025-11-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 11,687 | $0 |
| 2025-11-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 11,687 | $0 |
| 2025-11-18 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Sell | 15,894 | $141,616 |
| 2025-08-19 | Day One Biopharmaceuticals, Inc. (DAWN) | CHIEF EXECUTIVE OFFICER | Buy | 3,562 | $0 |
Source: SEC Form 4 filings · as of 2026-07-08